2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
NYSE Regulation accepted Actinium's compliance plan on August 12, 2026, and granted a plan period through November 27, 2027, to regain compliance with NYSE American continued listing standards. The company's common stock will keep trading on NYSE American during the plan period, but the company remains out of compliance with Sections 1003(a)(ii) and (iii) of the Company Guide.
NYSE American notified the company on May 27, 2026, that it was not in compliance with Sections 1003(a)(ii) and (iii) of the Company Guide.
The company submitted its compliance plan on June 18, 2026, and NYSE Regulation accepted it in an August 12, 2026 letter.
The plan period runs through November 27, 2027, and the stock continues to trade under the symbol ATNM during this period.
If the company does not regain compliance or make progress consistent with the plan by the end of the period, NYSE Regulation may initiate delisting proceedings.
Adagio Medical Holdings received a Nasdaq deficiency letter on August 13, 2026, saying it does not meet the minimum $2,500,000 stockholders' equity requirement for continued listing on the Nasdaq Capital Market. The company reported stockholders' equity of $(415,000) in its June 30, 2026 quarterly report, and the notice has no immediate effect on its listing. Shareholders should note the company must submit a compliance plan by September 28, 2026, and the company's filing cites going concern and financing risks.
Nasdaq notice received August 13, 2026 for stockholders' equity below $2,500,000 minimum
Reported stockholders' equity of $(415,000) in Form 10-Q for period ended June 30, 2026
Compliance plan due by September 28, 2026; Staff may grant up to 180 calendar days to regain compliance if plan is accepted
Company does not meet alternative standards of $35 million market value of listed securities or $500,000 net income
Optimum Communications received a New York Stock Exchange notice on August 13, 2026, because the average closing price of its Class A common stock fell below $1.00 over 30 consecutive trading days. The notice has no immediate effect on the stock's listing, but if the company does not regain compliance within six months, the NYSE will begin procedures to suspend and delist the shares.
NYSE notice received August 13, 2026, under Section 802.01C of the NYSE Listed Company Manual
Company has six months from receipt to regain compliance by meeting the $1.00 minimum closing and 30-day average price test
Company intends to monitor the share price through February 13, 2027; board will consider other options if compliance appears unlikely
Curing the price condition through an action requiring stockholder approval would need approval no later than the next annual meeting
On August 12, 2026, Reed's received a notice from NYSE American that it is below the $2.0 million stockholders' equity requirement and is not eligible for an exemption. NYSE American accepted the company's compliance plan that day, with a deadline of November 29, 2027 to regain compliance, and the company will face periodic reviews and possible delisting proceedings if it falls short.
Company reported a stockholders' deficit of $(1.5) million, below the $2.0 million NYSE American minimum.
NYSE American accepted the compliance plan, submitted June 26, 2026, on August 12, 2026.
Company must regain compliance by November 29, 2027, or NYSE American will initiate delisting proceedings as appropriate.
Shares continue to trade as REED with a ".BC" (below compliance) designation.
On August 13, 2026, the NYSE told SES AI that it will start proceedings to delist the company's public warrants and immediately suspend their trading for an abnormally low selling price. The warrants, ticker SES WS, carry a $11.50 exercise price and each is exercisable for one Class A share. Trading in the Class A common stock under SES continues and is unaffected.
NYSE notice received August 13, 2026, under Section 802.01D of the NYSE Listed Company Manual
Warrants (ticker SES WS) trading suspended immediately; delisting requires SEC application and completion of procedures
Each warrant exercisable for one Class A share at $11.50 per share
Class A common stock (SES) continues trading on the NYSE
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.